Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
Mattía Galli, Luis Ortega‐Paz, Francesco Franchi, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 13, pp. 723-737
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Antithrombotic Therapy in High Bleeding Risk, Part I
Mattía Galli, Felice Gragnano, Martina Berteotti, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2024) Vol. 17, Iss. 19, pp. 2197-2215
Open Access | Times Cited: 9
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
Mattía Galli, Dominick J. Angiolillo
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 31
Personalised antiplatelet therapies for coronary artery disease: what the future holds
Davide Capodanno, Dominick J. Angiolillo
European Heart Journal (2023) Vol. 44, Iss. 32, pp. 3059-3072
Closed Access | Times Cited: 22
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
Mattía Galli, Giovanni Occhipinti, Stefano Benenati, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 6, pp. 526-536
Closed Access | Times Cited: 7
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
Dominick J. Angiolillo, Mattía Galli, Dimitrios Alexopoulos, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2024) Vol. 17, Iss. 22, pp. 2639-2663
Closed Access | Times Cited: 6
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis
Mattía Galli, Renzo Laborante, G. Occhipinti, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 2, pp. 158-169
Closed Access | Times Cited: 16
AI-Driven Personalization of Dual Antiplatelet Therapy Duration Post-PCI: A Novel Approach Balancing Ischemic and Bleeding Risks in the UAE Population
Hassa Iftikhar
(2025)
Closed Access
Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
Jonathan Tjerkaski, Tomas Jernberg, Joakim Alfredsson, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 7, pp. 627-635
Open Access | Times Cited: 9
Precision Medicine Approaches in Cardiology and Personalized Therapies for Improved Patient Outcomes: A systematic review
Hyma Bamba, Gurmehar Singh, Jobby John, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 5, pp. 102470-102470
Closed Access | Times Cited: 3
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?
Pierre Sabouret, Luigi Spadafora, David L. Fischman, et al.
European Journal of Internal Medicine (2022) Vol. 110, pp. 1-9
Open Access | Times Cited: 14
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions
Victor Voicu, Nicolas Diehm, Igal Moarof, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 1, pp. 5-19
Open Access | Times Cited: 2
De-escalation versus shortening of dual antiplatelet therapy
Mattía Galli, Francesco Costa, Eliano Pio Navarese
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 4, pp. 267-269
Closed Access | Times Cited: 2
Bivalirudin in acute coronary syndromes
Mattía Galli, Marco Bernardi, Luis Ortega‐Paz, et al.
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 12, pp. 901-911
Open Access | Times Cited: 6
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management
Claudio Laudani, Davide Capodanno, Dominick J. Angiolillo
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 12, pp. 1193-1212
Closed Access | Times Cited: 6
The Lipid–Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity
Luis Ortega‐Paz, Francesco Franchi, Dominick J. Angiolillo
Thrombosis and Haemostasis (2024) Vol. 124, Iss. 06, pp. 528-532
Closed Access | Times Cited: 1
2024 ESC Guidelines on Chronic Coronary Syndromes: What is New in Pharmacotherapy?
Mattía Galli, Felice Gragnano, Christiaan Vrints, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 7, pp. 572-574
Closed Access | Times Cited: 1
Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular Disease
Mattía Galli, Gabriele Cortellini, Giovanni Occhipinti, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 18, pp. 1748-1766
Closed Access | Times Cited: 1
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
Felice Gragnano, Antonio Capolongo, Fabrizia Terracciano, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6246-6246
Open Access | Times Cited: 7
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based, Review
Gabriele Carciotto, Francesco Costa, Victoria Garcia-Ruiz, et al.
(2023)
Open Access | Times Cited: 3
P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention
Xuan Zhou, Dominick J. Angiolillo, Luis Ortega‐Paz
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 10, pp. 340-340
Open Access | Times Cited: 5
Precision antiplatelet therapy
Bianca Rocca, Carlo Patrono
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 3, pp. 100138-100138
Open Access | Times Cited: 2
Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
Ana Lucrecia Marcano, Montserrat Gracida, Gerard Roura, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies
Mattía Galli, Dominick J. Angiolillo
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 1-2, pp. 5-8
Open Access
Identifying and Overcoming Clopidogrel Resistance: Where Do We Stand?
Mattía Galli, Naveen L. Pereira
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 3, pp. 316-318
Open Access
High Bleeding Risk in Patients Undergoing Coronary and Structural Heart Interventions
Mattía Galli, Domenico D’Amario
Interventional Cardiology Clinics (2024) Vol. 13, Iss. 4, pp. 483-491
Closed Access
Page 1 - Next Page

Scroll to top